MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.717
-0.009 (-1.23%)
At close: Oct 4, 2024, 4:00 PM
0.751
+0.034 (4.69%)
After-hours: Oct 4, 2024, 4:17 PM EDT
MiNK Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 28 | 37 | 88 | 149 | - | - |
| Market Cap Growth | -48.31% | -58.11% | -40.99% | - | - | - |
| Enterprise Value | 23 | 31 | 64 | 214 | - | - |
| Last Close Price | 0.72 | 1.07 | 2.61 | 4.46 | - | - |
| PE Ratio | - | -1.64 | -3.14 | -3.84 | - | - |
| PB Ratio | -2.25 | -2.05 | -219.74 | 6.28 | - | - |
| P/FCF Ratio | -3.09 | -2.33 | -4.61 | -11.43 | - | - |
| P/OCF Ratio | -3.09 | -2.34 | -4.67 | -11.65 | - | - |
| EV/EBITDA Ratio | -2.07 | -1.34 | -2.08 | -11.55 | - | - |
| EV/EBIT Ratio | -2.05 | -1.33 | -2.07 | -11.50 | - | - |
| EV/FCF Ratio | -2.96 | -1.93 | -3.35 | -16.37 | - | - |
| Debt / Equity Ratio | -0.27 | - | - | - | -0.81 | -0.74 |
| Debt / FCF Ratio | -0.36 | - | - | - | -5.20 | -1.74 |
| Quick Ratio | 0.92 | 0.30 | 1.55 | 2.36 | 0.21 | 0.11 |
| Current Ratio | 0.93 | 0.32 | 1.61 | 2.41 | 0.29 | 0.12 |
| Return on Equity (ROE) | - | - | -239.50% | - | - | - |
| Return on Assets (ROA) | -97.25% | -110.10% | -62.69% | -51.92% | -230.14% | - |
| Return on Capital (ROIC) | - | - | -165.50% | -169.44% | - | - |
| Earnings Yield | -60.27% | -60.80% | -31.74% | -20.22% | - | - |
| FCF Yield | -42.68% | -42.87% | -21.68% | -8.75% | - | - |
| Buyback Yield / Dilution | -3.60% | -2.04% | -29.38% | -7.95% | -0.20% | - |
| Total Shareholder Return | -3.60% | -2.04% | -29.38% | -7.95% | -0.20% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.